Creatine Supplementation During GLP-1a Therapy

Recruiting now · Not applicable · Has a placebo group

Conditions studied: Sarcopenia

In brief

GLP-1 receptor agonists are effective for weight loss, but significant muscle mass is lost as a proportion of this weight loss. This study combines resistance-training and creatine supplementation to try to prevent this loss of muscle mass.

Key facts

Study ID

NCT07625202

Run by

University of Saskatchewan

People needed

40

Starts

2026-05-25

Expected to finish

2027-12-31

Last updated by the study team

2026-06-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Starting GLP-1 agonist therapy
• 18 years of age or older

You may not qualify if…

• Positive answers to a screening questionnaire for physical activity safety (the Get Active Questionnaire)

Where it is running

• University of Saskatchewan — Saskatoon, SK - Saskatchewan, Canada (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.